AbCellera (Nasdaq: ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL575, an investigational antibody ...

Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Summit Therapeutics (NASDAQ:SMMT) announced on Friday that its lead asset, ivonescimab, developed with its Chinese partner ...

Nearly thirty years ago an academic paper wrongly linked autism to a measles vaccine. The impacts are still being felt today.

US agency’s new policy could abruptly end studies of infectious diseases and cancer, leaving researchers scrambling for funds ...

References [1]  Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 2021; 9: 373–92. [2]  Institute ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Participating in clinical trials isn't just about personal survival—it's about creating a healthier future for loved ones.

This story contains details from testimony referencing suicide and suicidal ideations that are graphic, and some readers may ...

The FDA should now consider setting minimum thresholds for diverse inclusion, particularly in later-phase clinical trials. The FDA could also grant companies contingent approval (for example ...

Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM: San Francisco, US Tuesday, May 27, 2025, 11:00 Hrs [IST ...